Delivery Order 75N94023D00001-75N94026F00001
Award Date 9/28/26
Potential Completion Date 9/27/31
Potential Value $2.5M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD) to Westat, Inc., a prominent professional services firm. The contract, with a ceiling value of $1,125,154.00, requires Westat to coordinate, maintain, and manage NICHD participating sites for IMPAACT 2041, a Phase I/II study on the pharmacokinetics and safety of the hepatitis C drug combination of glecaprevir/pibrentasvir initiated in pregnancy, with and without...
- This is a delivery order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $923,533.10, was awarded to Westat, Inc., a for-profit professional services firm, for "IMPAACT INVESTIGATIONS FOR FUTURE STUDIES" from December 1, 2019, to November 30, 2021, with a potential completion date of May 31, 2023. The contract is a cost-plus-fixed-fee arrangement and...
- The National Institute of Child Health and Human Development (NICHD) awarded a $299,389 cost-plus-fixed-fee delivery order to Westat, Inc. on August 3, 2022, to support a Phase I clinical study examining the pharmacokinetics, safety, and acceptability of pretomanid as an addition to optimized background regimens in children with rifampicin-resistant tuberculosis (IMPAACT 2034). The contract, which extends through June 30, 2026, carries no small business set-aside designation and will be...
- The National Institute of Child Health and Human Development awarded a $11.02 million delivery order to Westat, Inc. for support services related to HIV/AIDS clinical trial networks, with an ultimate completion date of November 29, 2026. This delivery order operates under a larger $175 million single-award Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle established between NICHD and Westat for International and Domestic Pediatric and Maternal HIV Studies and Other Highly Infectious...
- The National Institute of Child Health and Human Development (NICHD) awarded Westat, Inc. a delivery order valued at $6.95 million for Task Order 4 under its larger $175 million Indefinite Delivery Vehicle for International and Domestic Pediatric and Maternal HIV Studies and Other Highly Infectious Diseases. This task order supports services for the prevention and treatment through a comprehensive care continuum for HIV-affected adolescents in resource-constrained settings implementation science...
- This is a Cost Plus Fixed Fee delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Westat, Inc., a for-profit professional services firm. The contract is for a study closeout of a randomized trial evaluating the virologic response and pharmacokinetics of two antiretroviral regimens in HIV-infected pregnant women. The contract has a ceiling value of $354,670.38 and a completion date of June 30, 2022. This work falls under...
- This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Westat, Inc., a for-profit professional services firm. The award, with a ceiling value of $6,111,243.76, is for "CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES", and is a Delivery Order type contract with a Cost Plus Fixed Fee pricing structure. The award does not use a set-aside designation. Westat, Inc. is the prime contractor, and...
- The National Institute of Child Health and Human Development issued a delivery order to Westat, Inc. on February 22, 2018, under a $175 million single-award IDIQ for International and Domestic Pediatric and Maternal HIV Studies and Other Highly Infectious Diseases. The delivery order, valued at $4,323,538.90, supports the International Prospective Observational Cohort Study of Zika in Infants and Pregnancy (ZIP Study), a cost-plus-fixed-fee effort with place of performance in Rockville, Maryland...
- The National Institute of Child Health and Human Development issued a delivery order to Westat, Inc. on September 14, 2018, under a $175 million single-award IDIQ for International and Domestic Pediatric and Maternal HIV Studies and Other Highly Infectious Diseases. The order carries a ceiling value of $2.7 million and covers an international cohort study of children born to women infected with Zika virus during pregnancy, with performance in Rockville, Maryland and ultimate completion by...
- The National Institute of Child Health and Human Development (NICHD) awarded Westat, Inc. a delivery order contract valued at approximately $2.97 million to support the Prevention and Treatment through Comprehensive Care Continuum for HIV-Affected Adolescents in Resource Constrained Settings (PATC3H) program. This Cost Plus Fixed Fee contract, awarded on December 12, 2018, with an ultimate completion date of December 11, 2023, falls under NICHD's International and Domestic Pediatric and Maternal...